Company / Return on Assets (ROA)
Apogee Therapeutics, Inc. Return on Assets (ROA) History
FY2022-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Assets (ROA)
-24.2%
FY2024
5-year range
-26.2% / -20.9%
FY2022-FY2024
Trend
-15.5%
vs FY2023
Sector context
#111 of 213
Health Care
What the data says
At -24.2%, Apogee Therapeutics, Inc.'s return on assets (roa) ranks #111 of 213 in the Health Care sector. Improved from -26.2% to -24.2% over the past 2 years.
Based on SEC 10-K filings.
-24.2% in FY2024.
Improved from -26.2% to -24.2% over the past 2 years.
Health Care sector context is included.
Return on Assets (ROA) over time
Growth rates
- 3-Year Change
- -
- 5-Year Change
- -
- 10-Year Change
- -
Sector benchmark
In line with sector averageTop 52% of 213This company -24.2% Sector average -24.1%
▼
In line with sector average
Key checks
Key Insights
- In FY2024, return on assets (roa) decreased 15.5% year-over-year.
- Currently 0.0pp below the Health Care sector average.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Assets (ROA)Value | YoY GrowthYoY |
|---|---|---|
| FY2024 | -24.2% | -15.5% |
| FY2023 | -20.9% | +20.0% |
| FY2022 | -26.2% | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026